Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome



Rating:

Share or cite this content

Citations should be made in the following way:
B. Cuomo, M. Cossettini, F. Saretta, L. Fasoli, T. Guerrera, M. Canciani (Udine, Italy). Efficacy of hypertonic saline solution in infant with acute bronchiolitis. Eur Respir J 2007; 30: Suppl. 51, 3016

Member's Comments

No comment yet.

Related content which might interest you: Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Nebulised hypertonic saline in the treatment of viral bronchiolitis in infants Source: ISSN=ISSN 1810-6838, ISBN=, page=160 Year: 2007 Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Effects of nebulizer therapy by hypertonic saline, gender and breastfeeding on evolution of acute bronchiolitis Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Hypertonic saline for acute viral bronchiolitis: take the evidence with a grain of salt Source: Eur Respir J 2014; 44: 827-830 Year: 2014 Hypertonic saline and acute wheezing in pre-school children Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Inhaled fraction and granulometry of hypertonic saline solution Aerosol for the ambulatory management of newborn babies with viral bronchiolitis: size matters. Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 Recovery and refractoriness following hypertonic saline challenge in asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Effectiveness of nebulised hypertonic saline on the respiratory management of children and young people with neuromuscular disease Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Is 5% saline safe and effective for acute bronchiolitis Source: Breathe 2010; 7: 198-199 Year: 2010 Oxygen saturation decrease after both isotonic and hypertonic saline inhalation in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 698s Year: 2005 Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Effects of intrabronchial terlipressin versus cold normal saline solution application in endobronchial bleeding Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007 Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis Source: ERJ Open Res, 6 (3) 00269-2020; 10.1183/23120541.00269-2020 Year: 2020 Refractoriness following hypertonic saline challenge attenuates nocturnal asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Comparison of magnesium sulfate to normal saline as a vehicle for nebulized salbutamol in children with acute asthma; a clinical trial Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021